Q3 2025 Anika Therapeutics Inc Earnings Call Transcript

Nov 5, 2025 / 01:30 PM GMT

Release Date Price: €8.35 (+1.21%)

Transcript 10-Q8-K

Key Points

Positve

Anika Therapeutics Inc (ANIK) reported strong commercial channel revenue growth of 22% year-over-year, driven by the integrity implant system and international OA pain management.
The company completed the filing of the third and final PMA module for Hyalofast, marking a significant milestone in its US regulatory pathway.
Anika Therapeutics Inc (ANIK) achieved a 25% year-over-year growth in regenerative solutions, with integrity procedures in the US growing for the sixth consecutive quarter.
The company reported strong operating cash flow of $6.9 million in the third quarter, up from $5 million in the same period last year.
Anika Therapeutics Inc (ANIK) is commencing a second $15 million share repurchase, reflecting its commitment to returning capital to shareholders.

Negative

Total revenue for the quarter declined by 6% compared to the same period last year, primarily due to pricing pressure in the OEM channel.
The OEM channel revenue declined by 20% in the third quarter, impacted by reduced pricing and a shift towards single injection treatments.
Gross margin decreased by 10 percentage points year-over-year, primarily due to a reduction in Monovisc and Orthovisc sales to J&J.
The company faced production-related disruptions in the second quarter, impacting shipment timing and resulting in a hangover effect in the third quarter.
Adjusted EBITDA from continuing operations declined by $3.7 million compared to the same period in 2024, primarily due to reduced high-margin revenue from J&J.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ANIK.OQ - Anika Therapeutics Inc
Q3 2025 Anika Therapeutics Inc Earnings Call
Nov 05, 2025 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning ladies and gentlemen and welcome to Annika's 3rd quarter earnings conference call. At this time all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press 0 for the operator.

I will now turn the call over to Matt Hall, director of corporate development and investor relations. Please proceed.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning and thank you for joining us for Annika's 3rd quarter 2025 conference call

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.